Haemonetics | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(5.6%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital Research Global Investors(8.7%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(8.27%),Wellington Group Holdings LLP(8.27%), etc.
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Galvin Roy
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Simon, Christopher
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Bryant Diane M
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director COYLE MICHAEL J
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director ABERNATHY ROBERT E
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Lloyd Emerson
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Dockendorff Charles J
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director KROLL MARK W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Zane Ellen M
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Pomeroy Claire
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Lingamneni Anila
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Simon, Christopher
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Lingamneni Anila
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Llorens Josep
No Data
No Data